Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Fund Overview

Min. investment

SIP ₹100 & Lump. ₹5000

AUM (Fund size)

6,801 Cr

Lock In Period

N/A

Expense Ratio

1.86

Benchmark

BSE Healthcare Total Return

Exit Load

1% of the applicable NAV - If units purchased or switched in from another scheme of the Fund are redeemed or switched out within 15 days from the date of allotment Nil.If units purchased or switched in from another scheme of the Fund are redeemed or switched out after 15 days from the date of allotment.

Summary

Latest details for ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth include a 38.23 NAV as of Mar 12,2026 and returns since inception of 110.34%. Minimum investments start at SIP ₹100. The ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth AUM is ₹6,801 Cr, with a lock-in of N/A years, expense ratio of 1.86%, and benchmark BSE Healthcare Total Return. Exit load is - 1% of the applicable NAV - If units purchased or switched in from another scheme of the Fund are redeemed or switched out within 15 days from the date of allotment Nil.If units purchased or switched in from another scheme of the Fund are redeemed or switched out after 15 days from the date of allotment.. In the growth review for 1M Month/Year, the fund recorded -0.21% returns, against a category average of -1.20% and a category best of 4.00%.

Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M-0.21-1.204.00
6M-5.061.788.52
1Y10.206.8416.41
3Y28.1317.58115.75

Portfolio Analysis

  • Equity: 97.61%
  • Debt: 2.41%
  • Others
As on: 2026-01-31
View allocation % by

1. Sun Pharmaceutical Industries Ltd.11.20%
2. Cipla Ltd.9.43%
3. Dr. Reddy's Laboratories Ltd.7.27%
4. Mankind Pharma Ltd.6.34%
5. Divi's Laboratories Ltd.6.22%
6. Biocon Ltd.5.85%
7. Lupin Ltd.4.80%
8. Aurobindo Pharma Ltd.3.91%
9. Syngene International Ltd.2.99%
10. Alkem Laboratories Ltd.2.90%
11. Cohance Lifesciences Ltd.2.80%
12. Zydus Lifesciences Ltd.2.34%
13. Alivus Life Sciences Ltd.2.28%
14. Alembic Pharmaceuticals Ltd.1.79%
15. Akums Drugs and Pharmaceuticals Ltd.1.63%
16. J.B.Chemicals & Pharmaceuticals Ltd.1.62%
17. Entero Healthcare Solutions1.60%
18. Gland Pharma Ltd.1.59%
19. Medplus Health Services Ltd1.45%
20. Pfizer Ltd.1.24%
21. Blue Jet Healthcare Ltd.1.16%
22. Glenmark Pharmaceuticals Ltd.1.15%
23. Hikal Ltd.1.15%
24. Windlas Biotech Ltd.1.09%
25. Aarti Drugs Ltd.1.04%
26. Anthem Biosciences Ltd0.95%
27. Shilpa Medicare Ltd.0.85%
28. Senores Pharmaceuticals Ltd0.76%
29. Astrazeneca Pharma India Ltd.0.75%
30. Rubicon Research Ltd0.74%
31. FDC Ltd.0.68%
32. Procter & Gamble Health Ltd.0.13%

1. Thyrocare Technologies Ltd.1.77%
2. Metropolis Healthcare Ltd.1.23%
3. Nephrocare Health Services Ltd0.44%

1. Medi Assist Healthcare Services Ltd1.44%

1. Fine Organic Industries Ltd.1.09%

About Fund

ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth managed by ICICI Prudential Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹6,801 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 1.86. Under the expert guidance of Dharmesh Kakkad ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Peer Comparison

Fund Name1Y3Y
This FundAditya Birla Sun Life Pharma & Healthcare Fund Growth11.982994.0667
This FundMirae Asset Healthcare Fund Growth14.751599.2946
This FundUTI Healthcare Fund Growth10.372899.315
This FundSBI Healthcare Opportunities Fund Growth8.708299.9745
This FundICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth10.2035110.3392

FAQs

ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth is 1.86. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth’s fund performance is as follows:
  • 1 Month : -0.21%
  • 6 Months : -5.06%
  • 1 Year : 10.20%
  • 3 Years : 28.13%
Returns of ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth are updated daily based on NAV of ₹ 38.23 as on Mar 12,2026. Since inception, the return has been 110.34%.

You can invest in ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth is ₹6,801 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
Min Inv Amount: ₹500